Valuation: Implantica AG

Market Cap 1.41B 1.63B 1.33B 1.21B 2.27B 157B 2.3B 15.58B 6.11B 78.34B 6.14B 6B 261B P/E 2026 *
-15.6x
P/E 2027 * -13.5x
Enterprise Value 1.39B 1.6B 1.3B 1.18B 2.23B 154B 2.26B 15.29B 5.99B 76.86B 6.02B 5.89B 256B EV / Sales 2026 *
388x
EV / Sales 2027 * 154x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -
1 day-3.64%
1 week+0.38%
Current month-14.24%
1 month-12.25%
3 months+21.00%
6 months+18.97%
Current year+5.79%
1 week 51.5
Extreme 51.5
55.1
1 month 50.8
Extreme 50.8
63
Current year 38
Extreme 38
69
1 year 38
Extreme 38
82
3 years 16
Extreme 16
86.4
5 years 15.4
Extreme 15.4
123.8
10 years 15.4
Extreme 15.4
178.9
Manager TitleAgeSince
Chief Executive Officer 72 2014-12-31
Director of Finance/CFO 48 2019-12-31
Corporate Officer/Principal 69 -
Director TitleAgeSince
Chairman 67 2019-12-31
Director/Board Member 62 2019-12-31
Director/Board Member 71 2019-12-31
Date Insider Type Main position Quantity % Market Cap.
9/24/25 Sell

Chief Financial Officer

16,700 0.0287%
9/24/25 Sell

Chief Financial Officer

17,100 0.0294%
9/24/25 Sell

Chief Financial Officer

29,500 0.0508%
Change 5-day change 1-year change 3-year change Capi.($)
-3.64%+0.38%-34.65%+116.77% 1.63B
-0.74%-0.47%+27.18%+29.27% 12.79B
-0.15%+0.46%+16.59%+31.76% 6.87B
-3.12%+1.48%+48.71%+45.18% 6.82B
-0.87%-2.12% - - 5.44B
+4.40%+3.14%-21.99%+59.37% 4.7B
-0.91%-3.09%-27.01%-22.74% 3.85B
-1.65%-2.38%+42.60%-44.48% 2.01B
-2.98%-6.65%+46.38%-9.25% 1.66B
-0.98%-0.04%-30.08%-42.68% 1.31B
Average -1.06%-0.13%+7.52%+18.13% 4.71B
Weighted average by Cap. -0.74%+0.40%+15.67%+26.95%

Financials

2026 *2027 *
Net sales 3.57M 4.13M 3.36M 3.05M 5.74M 396M 5.83M 39.4M 15.44M 198M 15.52M 15.18M 660M 9.14M 10.59M 8.6M 7.82M 14.71M 1.01B 14.92M 101M 39.55M 507M 39.75M 38.89M 1.69B
Net income -22.17M -25.67M -20.86M -18.96M -35.65M -2.46B -36.18M -245M -95.88M -1.23B -96.36M -94.27M -4.1B -25.65M -29.7M -24.14M -21.94M -41.26M -2.85B -41.87M -283M -111M -1.42B -112M -109M -4.74B
Net Debt -26.74M -30.96M -25.16M -22.87M -43.01M -2.97B -43.64M -295M -116M -1.48B -116M -114M -4.94B -308K -357K -290K -264K -496K -34.19M -503K -3.4M -1.33M -17.1M -1.34M -1.31M -56.95M
Logo Implantica AG
Implantica AG is Lichtenstein-based medical technology Company, whose mission is to provide effective treatment for serious health conditions and to improve patients' life through the use of advanced technologies in the human body, ultimately aiming to reduce costs and increase efficiency in the healthcare System. The therapies developed by Implantica are based on implants that are inserted into the patient's body and remain in the body permanently or semi-permanently to replace bodily functions and/or treat diseases. The Company focuses on the discovery, development and prospective commercialization of medical products and implants that are intended for use in different treatment fields like in the area of gastrointestinal surgery and urology. The Company's lead product is RefluxStop, a passive, implant to prevent gastroesophageal reflux disease (GERD).
Employees
-
Date Price Change Volume
26-08-19 SEK 53.00 -3.64% 13,030
26-08-18 SEK 55.00 +6.38% 47,825
26-08-17 SEK 51.70 -0.77% 27,406
26-08-14 SEK 52.10 -2.80% 31,714
26-08-13 SEK 53.60 +1.52% 43,130
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
4.983EUR
Average target price
6.725EUR
Spread / Average Target
+34.95%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IMP A SDB Stock